Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.04 USD | +2.97% |
|
+4.00% | +24.03% |
May. 09 | Sector Update: Health Care Stocks Higher Late Afternoon | MT |
May. 09 | X4 Pharmaceuticals Receives $125 Million Additional Capital; Shares Rise | MT |
Evolution of the average Target Price on X4 Pharmaceuticals, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
![Consensus](/images/consensus_flch.gif)
Consensus detail
Consensus revision (last 18 months)
Analysts covering X4 Pharmaceuticals, Inc.
HC Wainwright | |
B. Riley | |
Stifel Nicolaus | |
Oppenheimer | |
Cantor Fitzgerald | |
Piper Sandler | |
Canaccord Genuity |
EPS Revisions
- Stock Market
- Equities
- XFOR Stock
- Consensus X4 Pharmaceuticals, Inc.